The compliance assessment of endocrine therapy for breast cancer survivors:a review
10.3760/cma.j.issn.1672-7088.2017.20.015
- VernacularTitle:乳腺癌患者内分泌治疗服药依从性评估工具的研究进展
- Author:
Yanxin LIU
;
Ning JU
;
Qiuying ZHOU
;
Xiaoning BIAN
;
Jinzhao LIU
;
Xiao ZHANG
;
Liwei JING
;
Yan LIU
- Keywords:
Breast neoplasm;
Endocrine therapy;
Compliance;
Assessment tool
- From:
Chinese Journal of Practical Nursing
2017;33(20):1577-1581
- CountryChina
- Language:Chinese
-
Abstract:
Breast cancer is one of the most common cancers in China. With increasing of the incidence and mortality, the harm to women is becoming much serious. Estrogen positive patients need to take 5-10 years′ endocrine drugs to prolong survival and prevent recurrence. Endocrine therapy has become one of the most common and effective methods in the treatment of breast cancer. In order to achieve the desired effect of cancer treatment, reduce cancer metastasis and recurrence rate, good compliance is essential. In conclusion, this review summarizes the evaluation of compliance, various evaluation tools and their use.
